Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Oncology|January 1, 1990
Phase II clinical evaluation of etoposide (VP-16-213, Vepesid) as a second-line treatment in ovarian cancer. Results of the South-East European Oncology Group (SEEOG) StudyS Eckhardt, Z Hernádi, L Thurzó, et al.
Oncology|January 1, 1992
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerE Kánitz, K Kolaric, J Jassem, et al.
Oncology|January 1, 1988
Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group StudyS Eckhardt, E Juhos, I Hindy, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG)S Eckhardt, K Kolaric, D Vukas, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Treatment results of the thioether lipid ilmofosine in patients with malignant tumoursM Winkelmann, K Ebeling, G Strohmeyer, et al.
Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Neoplasma|January 1, 1987
Comparative evaluation of two administration schedules of cis-dichlorodiammineplatinum (DDP) in ovarian and head and neck cancers: a CMEA chemotherapy group studyZ Mechl, S Kerpel-Fronius, A Decker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group studyJ Jassem, F Gyergyay, S Kerpel-Fronius, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)S Kerpel-Fronius, V Erdélyi-Tóth, F Gyergyay, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 18, 2014
[Anakinra treatment in Schnitzler syndrome -  results of the first retrospective multicenter study in six patients from the Czech Republic]P Szturz, A Sedivá, M Zurek, et al.
Pageof 5